EDGAR Filing Documents for 0001104659-11-060824

Form 8-K - Current report:

SEC Accession No. 0001104659-11-060824

Filing Date

2011-11-04

Accepted

2011-11-04 07:31:10

Documents

Period of Report

2011-11-03

Items

Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a11-27166_138k.htm	8-K	43374
2	EX-10.1	a11-27166_13ex10d1.htm	EX-10.1	17354
3	EX-10.2	a11-27166_13ex10d2.htm	EX-10.2	174637
4	EX-99.1	a11-27166_13ex99d1.htm	EX-99.1	169248
5	EX-99.2	a11-27166_13ex99d2.htm	EX-99.2	11088
6	GRAPHIC	g2716613moi001.gif	GRAPHIC	15899
7	GRAPHIC	g2716613moi002.gif	GRAPHIC	57053
8	GRAPHIC	g2716613moi003.gif	GRAPHIC	41420
9	GRAPHIC	g2716613moi004.gif	GRAPHIC	47112
10	GRAPHIC	g2716613moi005.gif	GRAPHIC	41372
11	GRAPHIC	g2716613moi006.gif	GRAPHIC	45749
12	GRAPHIC	g2716613moi007.gif	GRAPHIC	43333
13	GRAPHIC	g2716613moi008.gif	GRAPHIC	14699
14	GRAPHIC	g2716613mmi001.jpg	GRAPHIC	2901
	Complete submission text file	0001104659-11-060824.txt		844960

Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421

Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300

AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)